Beta Drugs Financial Statements

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2020 - - -
Growth matrix (%)        
Revenue growth -- -- -- --
Op profit growth -- -- -- --
EBIT growth -- -- -- --
Net profit growth -- -- -- --
Profitability ratios (%)        
OPM 19.70 -- -- --
EBIT margin 16 -- -- --
Net profit margin 10.40 -- -- --
RoCE -- -- -- --
RoNW -- -- -- --
RoA -- -- -- --
Per share ratios ()        
EPS 9.79 -- -- --
Dividend per share -- -- -- --
Cash EPS 5.88 -- -- --
Book value per share 59.40 -- -- --
Valuation ratios        
P/E 4.09 -- -- --
P/CEPS 6.80 -- -- --
P/B 0.67 -- -- --
EV/EBIDTA 3.04 -- -- --
Payout (%)        
Dividend payout -- -- -- --
Tax payout (21) -- -- --
Liquidity ratios        
Debtor days -- -- -- --
Inventory days -- -- -- --
Creditor days -- -- -- --
Leverage ratios        
Interest coverage (5.60) -- -- --
Net debt / equity 0.30 -- -- --
Net debt / op. profit 0.96 -- -- --
Cost breakup ()        
Material costs (49) -- -- --
Employee costs (10) -- -- --
Other costs (21) -- -- --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2020 - - -
Revenue 90.80 -- -- --
yoy growth (%) -- -- -- --
Raw materials (44) -- -- --
As % of sales 48.80 -- -- --
Employee costs (9.50) -- -- --
As % of sales 10.40 -- -- --
Other costs (19) -- -- --
As % of sales 21 -- -- --
Operating profit 17.90 -- -- --
OPM 19.70 -- -- --
Depreciation (3.80) -- -- --
Interest expense (2.60) -- -- --
Other income 0.41 -- -- --
Profit before tax 12 -- -- --
Taxes (2.60) -- -- --
Tax rate (21) -- -- --
Minorities and other -- -- -- --
Adj. profit 9.42 -- -- --
Exceptional items -- -- -- --
Net profit 9.42 -- -- --
yoy growth (%) -- -- -- --
NPM 10.40 -- -- --
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2020 - - -
Profit before tax 12 -- -- --
Depreciation (3.80) -- -- --
Tax paid (2.60) -- -- --
Working capital -- -- -- --
Other operating items -- -- -- --
Operating cashflow -- -- -- --
Capital expenditure -- -- -- --
Free cash flow -- -- -- --
Equity raised -- -- -- --
Investments -- -- -- --
Debt financing/disposal -- -- -- --
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash -- -- -- --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2020 Mar-2019 Mar-2018 -
Equity capital 9.61 8.65 8.65 --
Preference capital -- -- -- --
Reserves 47.50 32.30 24.20 --
Net worth 57.10 40.90 32.90 --
Minority interest
Debt 22.60 20 7.50 --
Deferred tax liabilities (net) 0.23 0.15 0.15 --
Total liabilities 79.90 61 40.50 --
Fixed assets 43.90 32.40 14.50 --
Intangible assets
Investments 0.35 0.35 -- --
Deferred tax asset (net) 0.40 0.29 -- --
Net working capital 29.90 24.70 14.10 --
Inventories 12.40 9.53 2.80 --
Inventory Days 49.60 -- -- --
Sundry debtors 31.90 25 14.40 --
Debtor days 128 -- -- --
Other current assets 13.10 11.80 5.89 --
Sundry creditors (16) (16) (6.10) --
Creditor days 65.70 -- -- --
Other current liabilities (11) (6.10) (3) --
Cash 5.39 3.30 11.90 --
Total assets 79.90 61 40.50 --
Switch to
Consolidated
Standalone


Beta Drugs Ltd Report not showing data